Centre for History in Public Health, London School of Hygiene and Tropical Medicine

Maternova Appoints Luna Mehrain, MD, MSc, as Chief Medical Officer

Retrieved on: 
Wednesday, October 12, 2022
Medical Devices, Health, Consumer, Other Health, Baby, Maternity, General Health, International, Reproductive health, Master of Science, Sierra Leone, London School of Hygiene & Tropical Medicine, IPPF, Tropical medicine, International Planned Parenthood Federation, Medicine, Woman, Infant, University of Oxford, Organization, DAI, Mother, Patient, Research, Program, Mortality, Chief medical informatics officer, Technology, University, Population Services International, Health, Safety, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, PSI, Obstetrics, Solution, Public health, Pharmaceutical industry, Hygiene, MD

Maternova, Inc. , accelerating advances in maternal and infant health through innovative, accessible solutions, today announced the appointment of Luna M. Mehrain, MD, MSc, as Chief Medical Officer.

Key Points: 
  • Maternova, Inc. , accelerating advances in maternal and infant health through innovative, accessible solutions, today announced the appointment of Luna M. Mehrain, MD, MSc, as Chief Medical Officer.
  • She is a passionate clinician with a proven track record of championing health care for women and babies in resource-limited settings.
  • Her experience with prominent international organizations and expert medical knowledge make her an ideal addition to Maternova as we grow our life-saving product and technology offerings for health practitioners around the world, said Prakash Veenam, Chief Executive Officer, Maternova.
  • Maternova is a unique and trusted resource for medical innovations in newborn, obstetrics and reproductive health based on a deep understanding of the issues faced by clinicians and patients in low- and middle-income countries and humanitarian settings, said Luna Mehrain, MD, MSc, Chief Medical Officer, Maternova.

PharmaVentures' new Vice President recruited to lead Pricing and Market Access practice

Retrieved on: 
Tuesday, September 27, 2022
Commercial, Health, CEO, London School of Hygiene & Tropical Medicine, Biomedical sciences, NICE, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, Master of Science, Bachelor of Science, Tropical medicine, Public health, Pfizer, Pharmaceutical industry

LONDON, Sept. 27, 2022 /PRNewswire/ -- PharmaVentures is pleased to announce the appointment of Ralph Hughes as Vice President to lead its Pricing and Market Access practice.

Key Points: 
  • LONDON, Sept. 27, 2022 /PRNewswire/ -- PharmaVentures is pleased to announce the appointment of Ralph Hughes as Vice President to lead its Pricing and Market Access practice.
  • Ralph has built extensive experience in Pricing and Market Access, and also in Commercial assessment, through his various roles in the pharmaceutical industry.
  • For Mundipharma, he was responsible for the access and commercial launch strategy for key brands and for developing the commercial assessments for potential assets.
  • At Pfizer, he developed market access and pricing strategies globally and across multiple disease areas for early-stage and in-market assets.

PharmaVentures' new Vice President recruited to lead Pricing and Market Access practice

Retrieved on: 
Tuesday, September 27, 2022
Commercial, Health, CEO, London School of Hygiene & Tropical Medicine, Biomedical sciences, NICE, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, Master of Science, Bachelor of Science, Tropical medicine, Public health, Pfizer, Pharmaceutical industry

LONDON, Sept. 27, 2022 /PRNewswire/ -- PharmaVentures is pleased to announce the appointment of Ralph Hughes as Vice President to lead its Pricing and Market Access practice.

Key Points: 
  • LONDON, Sept. 27, 2022 /PRNewswire/ -- PharmaVentures is pleased to announce the appointment of Ralph Hughes as Vice President to lead its Pricing and Market Access practice.
  • Ralph has built extensive experience in Pricing and Market Access, and also in Commercial assessment, through his various roles in the pharmaceutical industry.
  • For Mundipharma, he was responsible for the access and commercial launch strategy for key brands and for developing the commercial assessments for potential assets.
  • At Pfizer, he developed market access and pricing strategies globally and across multiple disease areas for early-stage and in-market assets.

Curebase Names Medical Research Veteran Sean Lynch as VP of Clinical Operations

Retrieved on: 
Tuesday, August 23, 2022
University, Research, London School of Osteopathy, Genetics, SAN, University of London, Quintile, Tropical medicine, Physician, Lead, University College Cork, Cros, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, Clinical trial, DCT, Growth, Lviv, Patient, CRO, Pharmaceutical industry, IQVIA, Lynch

SAN FRANCISCO, Aug. 23, 2022 /PRNewswire/ -- Curebase , a company committed to democratizing access to clinical studies, has named veteran clinical research executive Sean Lynch as vice president of clinical operations.

Key Points: 
  • SAN FRANCISCO, Aug. 23, 2022 /PRNewswire/ -- Curebase , a company committed to democratizing access to clinical studies, has named veteran clinical research executive Sean Lynch as vice president of clinical operations.
  • The addition of Lynch will allow Curebase to further advance these clinical relationships and help to build a stronger clinical research industry.
  • "Sean is an experienced clinical trial professional with a strong business development background, which makes him ideal to lead our clinical operations," said Tom Lemberg, founder and chief executive officer of Curebase.
  • Prior to joining Curebase, Lynch was senior director of clinical project management at biotechnology research company TrialSpark.

Global Impact launches new $5M research fund - Vaccine Confidence Fund II to further understand how Social Media may be leveraged to Increase Vaccination Confidence and Uptake

Retrieved on: 
Friday, August 5, 2022
Online, MSD, Request for proposal, Public health, World Health Organization, Sabin Vaccine Institute, United Kingdom, Digital, GLOBE, Technology, World Bank, Digital economy, NJ, Research, Meta, Global Impact, Vaccine Confidence Project, Merck, World, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, COVID-19, Social media, Vaccine hesitancy, RFP, Program, Merck & Co., Associate, London School of Hygiene & Tropical Medicine, Centers for Disease Control and Prevention, Immunization, Vaccination, VCF, Insight dialogue, Natural language processing, Tropical medicine, Health, Organization, Pharmaceutical industry, Fund, Hygiene

This round of funding for global research will focus on harnessing the power of social media to increase vaccination confidence and uptake with an emphasis on enhancing routine immunization and educating health care workers on addressing vaccine hesitancy.

Key Points: 
  • This round of funding for global research will focus on harnessing the power of social media to increase vaccination confidence and uptake with an emphasis on enhancing routine immunization and educating health care workers on addressing vaccine hesitancy.
  • Global Impact is publishing the Full Insights Report on the first Vaccine Confidence Fund which features findings from the grantees research and insights on potential ways to drive vaccination confidence and uptake.
  • Through these partnerships, Global Impact has raised nearly $2 billion for causes such as disaster relief and global development.
  • Global Impacts reach and services are complemented by the work of its subsidiary company, Geneva Global .

Global Impact, on Behalf of the Alliance for Advancing Health Online (AAHO), Shares Research and Announces Upcoming New Program at 75th World Health Assembly

Retrieved on: 
Wednesday, May 25, 2022
Online, MSD, University of California, Institute for Prediction Technology, Global Impact, RFP, Associate professor, Vaccine Confidence Project, Social media, Public health, Â, World, Sabin Vaccine Institute, Vaccine hesitancy, Digital economy, Woman, World Health Organization, Merck & Co., Vaccination, Chatbot, Health, World Health Assembly, Doctor of Science, Associate, Regulation Focused Psychotherapy for Children (RFP-C), Centers for Disease Control and Prevention, Meta, COVID-19, WhatsApp, Merck, University of California, Research, Digital, Tropical medicine, World Bank, Immunization, NJ, Program, University, Technology, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, London School of Hygiene & Tropical Medicine, GLOBE, Pharmaceutical industry, Obstetrics, Fund, Hygiene

The global research is intended to reveal insights on how to harness social media and online engagement to drive vaccine confidence.

Key Points: 
  • The global research is intended to reveal insights on how to harness social media and online engagement to drive vaccine confidence.
  • Global Impact sought proposals that address how social media can be best utilized to better understand vaccine hesitancy and increase vaccination confidence and uptake.
  • Through these partnerships, Global Impact has raised nearly $2 billion for causes such as disaster relief and global development.
  • Global Impacts reach and services are complemented by the work of its subsidiary company, Geneva Global .

Covalon Announces Changes to its Board of Directors

Retrieved on: 
Thursday, March 10, 2022
Government, Industry, Community, Child, Tropical medicine, University, Risk, Company, McMaster University, COV, Royal college, Woman, FRCPC, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, London School of Medicine for Women, Physician, MD, Order of Ontario, Health, News, Multimedia, College, Board, Board of directors, Master of Science, Order, Royal College of Physicians and Surgeons of Canada, Fellow, CCFP, TSX Venture Exchange, TSX, Knowledge, Public health, COVID-19, Surgeon, War Child (charity), Women's College Hospital, Assistant, FCPC, Management, Pharmaceutical industry, Hygiene, Medicine

Dr. Nutt has been appointed to the Order of Canada and is a recipient of the Order of Ontario.

Key Points: 
  • Dr. Nutt has been appointed to the Order of Canada and is a recipient of the Order of Ontario.
  • "We are delighted that Dr. Nutt has joined Covalon's Board," said Brian Pedlar, Chief Executive Officer.
  • "Her specialized medical expertise and extraordinary philanthropic achievements will be a tremendous asset to Covalon."
  • Amir Boloor, Chair of Covalon's Board of Directors, said, "We are extremely grateful for Marty's numerous contributions as a Director, supporter, and mentor to Covalon for many years.

First cohort of Reckitt Global Hygiene Institute fellows will help plug significant gaps in hygiene research

Retrieved on: 
Thursday, February 17, 2022
Health, Adoption, Epidemiology, Attention, World, School, Poultry, Research, Tropical medicine, Diarrhea, Infection, Capacity building, Travel, Economics, London School of Hygiene & Tropical Medicine, Institute, WHO, Fellows, Policy, Public health, Engineering, Multimedia, World Health Organization, COVID-19, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, Efficiency, Sociology, WASH, Fellow, Cholera, Animal, Restaurant, Medicine, Hygiene

The fellows' research will, over the next three years, contribute to filling the current void in health and hygiene research and help to generate better hygiene practises that could save lives.

Key Points: 
  • The fellows' research will, over the next three years, contribute to filling the current void in health and hygiene research and help to generate better hygiene practises that could save lives.
  • Hygiene, according to the World Health Organization, "refers to conditions and practises that help to maintain health and prevent the spread of diseases."
  • So far, evidence and research on this topic has been lacking, resulting in significant information deficits that have come to the fore amid COVID-19.
  • Research topics of interest to RGHI include basic research, clinical investigation, epidemiology, behavioural science, sociology, health economics and engineering.

Macro-Eyes selected by the Vaccine Confidence Fund to Boost Vaccination Confidence through Social Media

Retrieved on: 
Wednesday, January 26, 2022
Online, COVID-19, VCF, Vaccine, London School of Hygiene & Tropical Medicine, Merck & Co., Science, World, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, Sabin Vaccine Institute, Vaccine-preventable diseases, Anthrax Vaccine Immunization Program, Merck, Social media, Vaccine Confidence Project, Vaccine hesitancy, Centers for Disease Control and Prevention, Global Impact, Alliance, Vaccination, Multimedia, Research, Organization, Immunization, Program, Tropical medicine, Public health, Technology, MIT, Health, World Bank, Pharmaceutical industry, Hygiene, Facebook

The Vaccine Confidence Fund (VCF) is the flagship program of the Alliance for Advancing Health Online (AAHO) , whose members include the CDC Foundation , the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, the World Bank , Merck & Co ., and Facebook.

Key Points: 
  • The Vaccine Confidence Fund (VCF) is the flagship program of the Alliance for Advancing Health Online (AAHO) , whose members include the CDC Foundation , the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, the World Bank , Merck & Co ., and Facebook.
  • "Building confidence in vaccination is critical to reducing vaccine hesitancy, which threatens to stall and even reverse progress made in combating vaccine-preventable diseases worldwide," said John H. Markels, President, Merck Vaccines.
  • "Supporting the public health efforts to increase vaccine confidence has been our top priority," said KX Jin, Facebook 's Head of Health.
  • The Vaccine Confidence Fund, financially supported by Facebook and Merck & Co , is the first flagship program of the Alliance for Advancing Health Online (AAHO).

Macro-Eyes selected by the Vaccine Confidence Fund to Boost Vaccination Confidence through Social Media

Retrieved on: 
Wednesday, January 26, 2022
Online, COVID-19, VCF, Vaccine, London School of Hygiene & Tropical Medicine, Merck & Co., Science, World, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, Sabin Vaccine Institute, Vaccine-preventable diseases, Anthrax Vaccine Immunization Program, Merck, Social media, Vaccine Confidence Project, Vaccine hesitancy, Centers for Disease Control and Prevention, Global Impact, Alliance, Vaccination, Research, Organization, Immunization, Program, Tropical medicine, Public health, Technology, MIT, Health, World Bank, Pharmaceutical industry, Hygiene, Facebook

The Vaccine Confidence Fund (VCF) is the flagship program of the Alliance for Advancing Health Online (AAHO) , whose members include the CDC Foundation , the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, the World Bank , Merck & Co ., and Facebook.

Key Points: 
  • The Vaccine Confidence Fund (VCF) is the flagship program of the Alliance for Advancing Health Online (AAHO) , whose members include the CDC Foundation , the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, the World Bank , Merck & Co ., and Facebook.
  • "Building confidence in vaccination is critical to reducing vaccine hesitancy, which threatens to stall and even reverse progress made in combating vaccine-preventable diseases worldwide," said John H. Markels, President, Merck Vaccines.
  • "Supporting the public health efforts to increase vaccine confidence has been our top priority," said KX Jin, Facebook 's Head of Health.
  • The Vaccine Confidence Fund, financially supported by Facebook and Merck & Co , is the first flagship program of the Alliance for Advancing Health Online (AAHO).